Literature DB >> 2146321

Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays.

M Oppermann1, H Baumgarten, E Brandt, W Gottsleben, C Kurts, O Götze.   

Abstract

Sensitive enzyme-linked immunosorbent assays (ELISA) using monoclonal antibodies have been developed to specifically detect components of the alternative pathway of complement in human blood plasma. Normal values of the factor B split products Ba (1.01 +/- 0.30 micrograms/ml, mean +/- SD), Bb (0.65 +/- 0.23 micrograms/ml), of the C3-fragments C3b/iC3b/C3dg (17.9 +/- 5.7 micrograms/ml), native factor B (238 +/- 48 micrograms/ml), factor D (1.05 +/- 0.27 micrograms/ml), and factor H (702 +/- 292 micrograms/ml) were determined in the EDTA-plasma of healthy probands (n = 55). The simultaneous quantitation of the main cleavage products and of control proteins in the plasma samples permits precise analysis of the activation of the alternative pathway of complement in various disease states. In addition, we describe a method for the specific depletion of factor B prior to fragment-specific assays utilizing monoclonal antibodies conjugated to paramagnetic beads. The latter should permit the quantitation of other complement split products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146321     DOI: 10.1016/0022-1759(90)90358-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.

Authors:  G Schlaf; E Rothermel; M Oppermann; H L Schieferdecker; K Jungermann; O Götze
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 2.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

Review 3.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

4.  Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.

Authors:  Laura A Hecker; Albert O Edwards; Euijung Ryu; Nirubol Tosakulwong; Keith H Baratz; William L Brown; Peter Charbel Issa; Hendrik P Scholl; Beatrix Pollok-Kopp; Katharina E Schmid-Kubista; Kent R Bailey; Martin Oppermann
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

5.  Systemic complement activation in age-related macular degeneration.

Authors:  Hendrik P N Scholl; Peter Charbel Issa; Maja Walier; Stefanie Janzer; Beatrix Pollok-Kopp; Florian Börncke; Lars G Fritsche; Ngaihang V Chong; Rolf Fimmers; Thomas Wienker; Frank G Holz; Bernhard H F Weber; Martin Oppermann
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

Review 6.  Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics.

Authors:  Maedeh Mohebnasab; Oskar Eriksson; Barbro Persson; Kerstin Sandholm; Camilla Mohlin; Markus Huber-Lang; Brendan J Keating; Kristina N Ekdahl; Bo Nilsson
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

7.  Mathematical Modelling of Alternative Pathway of Complement System.

Authors:  Suruchi Bakshi; Fraser Cunningham; Eva-Maria Nichols; Marta Biedzka-Sarek; Jessica Neisen; Sebastien Petit-Frere; Christina Bessant; Loveleena Bansal; Lambertus A Peletier; Stefano Zamuner; Piet H van der Graaf
Journal:  Bull Math Biol       Date:  2020-02-15       Impact factor: 1.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.